Organon To Report Second Quarter 2025 Results and Host Conference Call on August 5, 2025
Organon (NYSE: OGN), a global healthcare company focused on women's health, has scheduled its second quarter 2025 financial results announcement for August 5, 2025.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Accessing Second Quarter 2025 Financial Results Webcast
Interested parties may access the live call via webcast on the Organon website at https://www.organon.com/investor-relations/events-and-presentations/. A replay of the webcast will be available approximately two hours after the conclusion of the live event on the company’s website.
Institutional investors and analysts interested in participating in the call may join by dialing (888) 596-4144 (
About Organon
Organon (NYSE: OGN) is a global healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. With a portfolio of over 70 products across Women’s Health and General Medicines, which includes biosimilars, Organon focuses on addressing health needs that uniquely, disproportionately or differently affect women, while expanding access to essential treatments in over 140 markets.
Headquartered in
View source version on businesswire.com: https://www.businesswire.com/news/home/20250722000126/en/
Organon Media Contacts:
Felicia Bisaro
(646) 703-1807
Organon Investor Contacts:
Jennifer Halchak
(201) 275-2711
Renee McKnight
(551) 204-6129
Source: Organon & Co.